Clinical Trials
4
Active:0
Completed:4
Trial Phases
1 Phases
Phase 4:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)β’ Click on a phase to view related trials
Phase 4
3 (100.0%)Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of Migraine
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2012-01-13
- Lead Sponsor
- Clinvest
- Target Recruit Count
- 55
- Registration Number
- NCT00846495
- Locations
- πΊπΈ
Physician Associates LLC, Oviedo, Florida, United States
πΊπΈClinvest, Springfield, Missouri, United States
Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of Migraine
Completed
- Conditions
- Headache, Migraine
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2009-05-25
- Lead Sponsor
- Clinvest
- Target Recruit Count
- 34
- Registration Number
- NCT00772473
- Locations
- πΊπΈ
Clinvest, Springfield, Missouri, United States
Two Rizatriptan Prescribing Portions for Treatment of Migraine
- First Posted Date
- 2006-11-09
- Last Posted Date
- 2010-06-08
- Lead Sponsor
- Clinvest
- Target Recruit Count
- 197
- Registration Number
- NCT00397254
- Locations
- πΊπΈ
Brian Koffman, MD, Diamond Bar, California, United States
πΊπΈSan Francisco Clinical Research Center, San Francisco, California, United States
πΊπΈPhysician Associates, Oviedo, Florida, United States
Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers
Phase 4
Completed
- Conditions
- SinusitisMigraine
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2009-05-06
- Lead Sponsor
- Clinvest
- Target Recruit Count
- 50
- Registration Number
- NCT00208065
- Locations
- πΊπΈ
Clinvest, Inc., Springfield, Missouri, United States
News
No news found